American Well Corporation announced the appointment of Ricky Goldwasser its Board of Directors, effective June 13, 2024. Ms. Goldwasser has spent her career advising institutional investors and public and private companies across the healthcare services continuum. She spent 15 years at Morgan Stanley where she was a managing director, head of U.S. Healthcare Services & Technology Research and most recently Investment Banking groups, and was co-head of U.S. Healthcare Research at UBS.

Throughout her career, she has led many successful initial public offerings, including Amwell?s, and has been recognized by Institutional Investor magazine as a top-ranked research analyst for 18 years. Ms. Goldwasser will take the place of departing board member Deval Patrick, who has served on the Amwell board since 2015.